Pharma
Walgreens Pharmacist Refused To Give A Woman Her Prescription To End A Pregnancy
A Walgreens pharmacist refused to give a woman her prescription because of “ethical beliefs”<p>Today in truly repulsive news, a Walgreens pharmacist …
WalgreensSanofi, Novo Nordisk and Lilly named in patients' price fixing suit | Reuters
NEW YORK (Reuters) - Three of the biggest makers of diabetes treatments, Sanofi SA, Novo Nordisk and Eli Lilly and Co, were named in a class action lawsuit about price fixing filed by a group of patients.<p>The logo of French drugmaker Sanofi is seen in front of the company's headquarters in Paris, …
Eli LillyOntario Promotes Free Use of Opioid Antidote
Harm-reduction program saves lives, say advocates who want to see naloxone provided to U.S. addicts<p>TORONTO—By his own account, Leon “Pops” Alward should be dead. The 47-year-old Toronto resident has overdosed five times in the past four years after injecting the synthetic opioid fentanyl. He is …
NaloxoneRare diseases, expensive drugs - Health Canada showdown coming
When Canada’s health ministers sit down together on Thursday and Friday in Winnipeg, talks are expected to revolve around Ottawa’s development of a national pharmacare plan. B.C. Health Minister Adrian Dix wants that plan to include a mechanism to grapple with expensive drugs for rare diseases – a …
Canadian NewsLupin to launch nearly 30 products in US market this fiscal
With rapid approvals from US health regulator anticipated, Lupin sees opportunity to launch around 30 generic products in the world’s largest pharma
Business (India)A Drug Costs $272,000 a Year. Not So Fast, Says New York State.
A wave of breakthrough drugs is transforming the medical world, offering hope for people with deadly diseases despite their dizzying price tags.<p>But what if it turns out that some of these expensive new drugs don’t work that well?<p>That’s the quandary over Orkambi, a drug that was approved in 2015 for …
BusinessNICE reconsiders and agrees to back Roche’s Ocrevus in relapsing multiple sclerosis—with strings attached
In April, England’s cost watchdog decided Roche’s multiple sclerosis star Ocrevus wasn’t cost-effective enough to win reimbursement backing in …
Multiple SclerosisPharmacy middlemen made $223.7M from Ohio Medicaid
For the first time, the state of Ohio on Friday released data showing how private companies manage $2.5 billion in public money for pharmacy benefits …
Health CareSide Effects series on prescription drugs
The Dispatch has spent the past four months uncovering how PBMs operate in Ohio. The stories have detailed some of the hidden costs PBMs create that …
PharmaFDA slaps new bladder cancer limits on Merck's Keytruda, Roche's Tecentriq
Last month, the FDA warned that immuno-oncology stars from Merck and Roche might actually be hurting some previously untreated bladder cancer …
ImmunotherapyU.S. District Court rules in favor of Lilly's Alimta patent
June 22 (Reuters) - Eli Lilly and Co said on Friday a U.S. District Court ruled in favor of its patent on Alimta vitamin regimen and prevented …
JudiciaryGovernment accelerates approvals for imported medicines
China's State Drug Administration has accelerated the approval of imported drugs that have already been tested and approved for use in overseas …
News (China)Opioid shortages leave US hospitals scrambling
Even as opioids flood American communities and fuel widespread addiction, hospitals are facing a dangerous shortage of the powerful painkillers for patients in acute pain, according to doctors, pharmacists and a coalition of health groups.<p>The shortage, though more significant in some places than …
MedicineDrug shortages again on the rise after 5 years of improvements, FDA says
After 5 years of declines in the number of new drug shortages in the U.S., they jumped to 39 last year from 26 in the two preceding years. And while …
PharmaShire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
When CSL launched its hereditary angioedema drug Haegarda last year, it played up one big advantage the drug has over Shire’s Cinryze: Haegarda can …
PharmaAmerican Medical Association urges regulators to block CVS-Aetna deal
The American Medical Association has weighed in against the $69 billion acquisition of Aetna Inc. by CVS Health Corp., saying it will leave consumers …
Health CareWhy is AbbVie’s tax rate so low? Humira patents cached in Bermuda
Humira is the world's bestselling drug, marketed by the Big Pharma company that’s expecting to chalk up the lowest tax rate in the industry this …
Eli LillyDrug Pricing Turns to Insulin As Politicians, AMA And Docs Look to Pharma
Eli Lilly & Co. (ELY) , Sanofi Inc. (SNY) , Novo Nordisk (NVO) and Merck & Co. (MRK) are being put on the defensive.<p>Those huge pharma companies …
Eli LillyDrug spoon sculpture placed outside drugmaker headquarters
STAMFORD, Conn. (AP) — An 800-pound, nearly 11-foot-long steel sculpture of a bent and burned drug spoon was placed Friday in front of the Connecticut headquarters of drugmaker Purdue Pharma as part of an art protest against the opioid crisis.<p>Artist Domenic Esposito and art gallery owner Fernando …
Purdue PharmaCVS tool finds cheaper drug options - Atlanta Journal-Constitution
HEALTH CARE<p>CVS Health is rolling out a new tool to alert its 30,000 pharmacists to cheaper drug options when they fill patients’ prescriptions.<p>For …
CVS Pharmacy2,000 Iowans could get free Narcan spray to revive opioid overdose victims
CLOSE<p>Opioid abuse is at an all-time high, say experts, and the medication naloxone, if administered in time, could prevent a fatal overdose. This …
Des MoinesExpress Scripts says Anthem negotiated in bad faith: court filing | Reuters
(Reuters) - Pharmacy benefit manager Express Scripts Holding Co has accused Anthem Inc of negotiating their contract in bad faith and is seeking a court order that the health insurer has no right to demand lower drug prices.<p>The office building of health insurer Anthem is seen in Los Angeles, …
Express ScriptsFormer Sale’s Rep Accuses OxyContin Maker Of ‘Disturbing’ Marketing Practices Used To Push Pills After $635 Million Settlement
7:27 PM 06/22/2018<p>A former sale’s representative for Purdue Pharma is accusing the drug maker of continuing to misrepresent its opioid medication …
Conservative ViewThe woman behind 'female Viagra' sold her company for $1 billion — then got it back for free
In 2015, Cindy Eckert (then Whitehead) made headlines after landing a billion-dollar deal for the company she co-founded, Sprout Pharmaceuticals, …
PharmaCVS Pharmacies Now Delivers Prescriptions Nationwide
CVS Pharmacy is the nation’s first retail chain to deliver prescriptions. Next-day home delivery is now available from all of its 9,800 locations …
CVS Pharmacy374 Californians took their lives in 2017 under physician-assisted suicide law
A total of 374 people in California took their lives in 2017 using lethal medications prescribed by their doctors under the state’s physician-assisted suicide law, according to state data released Friday.<p>The End of Life Option Act, which went into effect in June 2016, made the state the fifth to …
PharmaCVS Health CEO Larry Merlo: Confident Aetna deal will close later this year
CVS Health CEO Larry Merlo told CNBC on Thursday he's "excited" and confident about the drugstore chain's deal to merge with Aetna.<p>The $69 billion …
CVS Health16+ Terms Entrepreneurs Should Know for Navigating the Healthcare Industry
The U.S. spends over $3 trillion annually and healthcare accounts approaches 20% of our GDP — this is clearly an industry that is ripe with …
Ben HorowitzFirst Female Dean ‘A Sea Of Change’ At USC’s Scandal-Plagued Medical School
The University of Southern California veered sharply and deliberately from tradition in naming the first woman — and the first geriatrician — to lead its 133-year-old medical school.<p>Dr. Laura Mosqueda, who took over the position on May 1, said she’ll work hard to steer more young doctors toward …
PharmaExpress Scripts shares languish as Anthem dispute weighs | Reuters
NEW YORK (Reuters) - As a pharmacy benefits manager geared toward holding down prescription costs, Express Scripts would appear to be in a sweet spot with rising political and public pressure on drug prices, but its stock has struggled this year.<p>The main culprit: a contract dispute with a major …
Express Scripts